Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection
- PMID: 22969227
- PMCID: PMC3435779
- DOI: 10.3748/wjg.v18.i33.4542
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection
Abstract
Aim: To determine the efficacy of our therapeutic strategy for Helicobacter pylori (H. pylori) eradication and to identify predictive factors for successful eradication.
Methods: From April 2006 to June 2010, we retrospectively assessed 2428 consecutive patients (1025 men, 1403 women; mean age 55 years, age range 18-92 years) with gastric histology positive for H. pylori infection referred to our unit for 13-C urea breath test (UBT), after first-line therapy with proton pump inhibitor (PPI) b.i.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 d. Patients who were still positive to UBT were recommended a second-line therapy (PPI b.i.d. + amoxicillin 1 g b.i.d. + tinidazole 500 mg b.i.d. for 14 d). Third choice treatment was empirical with PPI b.i.d. + amoxicillin 1 g b.i.d. + levofloxacin 250 mg b.i.d. for 14 d.
Results: Out of 614 patients, still H. pylori-positive after first-line therapy, only 326 and 19 patients respectively rechecked their H. pylori status by UBT after the suggested second and third-line regimens. "Per protocol" eradication rates for first, second and third-line therapy were 74.7% (95% CI: 72.7%-76.4%), 85.3% (95% CI: 81.1%-89.1%) and 89.5% (95% CI: 74.9%-103%) respectively. The overall percentage of patients with H. pylori eradicated after two treatments was 97.8% (95% CI: 97.1%-98.4%), vs 99.9% (95% CI: 99.8%-100%) after three treatments. The study found that eradication therapy was most effective in patients with ulcer disease (P < 0.05, P = 0.028), especially in those with duodenal ulcer. Smoking habits did not significantly affect the eradication rate.
Conclusion: First-line therapy with amoxicillin and clarithromycin produces an H. pylori eradication rate comparable or superior to other studies and second-line treatment can still be triple therapy with amoxicillin and tinidazole.
Keywords: Eradication rate; Eradication treatment; First-line therapy; Helicobacter pylori; Rescue therapy; Second-line therapy; Triple therapy.
Figures
Similar articles
-
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?BMC Gastroenterol. 2017 Feb 15;17(1):31. doi: 10.1186/s12876-017-0589-6. BMC Gastroenterol. 2017. PMID: 28202013 Free PMC article.
-
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.Am J Gastroenterol. 2008 Jan;103(1):71-6. doi: 10.1111/j.1572-0241.2007.01500.x. Epub 2007 Aug 31. Am J Gastroenterol. 2008. PMID: 17764498 Clinical Trial.
-
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351. World J Gastroenterol. 2015. PMID: 25574111 Free PMC article. Clinical Trial.
-
Helicobacter pylori eradication therapy.Future Microbiol. 2010 Apr;5(4):639-48. doi: 10.2217/fmb.10.25. Future Microbiol. 2010. PMID: 20353303 Review.
-
Second-line rescue treatment of Helicobacter pylori infection: Where are we now?World J Gastroenterol. 2018 Oct 28;24(40):4548-4553. doi: 10.3748/wjg.v24.i40.4548. World J Gastroenterol. 2018. PMID: 30386104 Free PMC article. Review.
Cited by
-
Real-Time PCR detection and quantitation of Helicobacter pylori clarithromycin-resistant strains in archival material and correlation with Sydney classification.Ann Gastroenterol. 2013;26(3):226-232. Ann Gastroenterol. 2013. PMID: 24714278 Free PMC article.
-
Rescue Therapies for H. pylori Infection in Italy.Antibiotics (Basel). 2021 May 3;10(5):525. doi: 10.3390/antibiotics10050525. Antibiotics (Basel). 2021. PMID: 34063624 Free PMC article.
-
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection.Therap Adv Gastroenterol. 2016 Jul;9(4):437-48. doi: 10.1177/1756283X15621229. Epub 2015 Dec 16. Therap Adv Gastroenterol. 2016. PMID: 27366212 Free PMC article. Review.
References
-
- Marshall B. Helicobacter pylori Research Laboratory. Available from: http//www.hpylori.com.au/
-
- World Gastroenterology Organisation. World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries. J Clin Gastroenterol. 2011;45:383–388. - PubMed
-
- Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–577. - PubMed
-
- Bertoni F, Coiffier B, Salles G, Stathis A, Traverse-Glehen A, Thieblemont C, Zucca E. MALT lymphomas: pathogenesis can drive treatment. Oncology (Williston Park) 2011;25:1134–1142, 1147. - PubMed
-
- Fiocca R, Luinetti L, Villani L, Chiaravalli A, Cornaggia M, Stella G, Perego M, Trespi E, Solcia E. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol. 1993;5:S2–S8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous